The global cancer tumor profiling market reached a value of US$ 9.38 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 18.22 Billion by 2027 exhibiting a growth rate (CAGR) of 11.20% during 2022-2027. More Info:- https://www.imarcgroup.com/cancer-tumor-profiling-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Cancer/Tumor Profiling
Market Research and Forecast
Report 2022-2027
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Cancer/Tumor Profiling Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled "Cancer/Tumor Profiling Market: Global
Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global cancer
tumor profiling market reached a value of US$ 9.38 Billion in 2021.
Cancer/tumor profiling, or biomarker testing, is a process of identifying specific proteins, genes, gene
mutations (changes), and other biomarkers in a tumor tissue sample. It assists in determining
whether the pathways of a tumor match up with the available targeted therapies. It is also used for
therapeutic decision-making, routine diagnostics, and personalized treatment plans and therapies
based on the severity of the ailment and genomic build-up.
As a result, cancer/tumor profiling finds extensive applications in the discovery of biomarkers,
research, personalized medicines, and the development of screening and diagnostic techniques.
Request for a PDF sample of this report: https://www.imarcgroup.com/cancer-tumor-profiling-
market/requestsample

4. Report Description
Report Description and Highlights
Global Cancer/Tumor Profiling Market Trends:
The market is primarily driven by the increasing prevalence of cancer across the globe. In addition, the
growing inclination toward personalized medicine among the masses represents another major growth-
inducing factor. Besides this, governments of numerous countries are investing in cancer research to
develop advanced techniques to reduce the time taken for the detection and identification of tumors.
This, coupled with the increasing investments by pharmaceutical and biotechnology companies in
research and development (R&D) activities for introducing novel therapies and new drug-designing
techniques, is positively influencing the market growth.
Furthermore, recent advancements in molecular biology techniques, the rising number of clinical trials,
the increasing adoption of immunoassay techniques, and the developing healthcare infrastructure
across the globe are some of the other factors creating a positive market outlook across the globe.
Looking forward, IMARC Group expects the market to reach a value of US$ 18.22 Billion by 2027,
exhibiting a CAGR of 11.20% during the forecast period (2022-2027).
View Report TOC, Figures and Tables: https://www.imarcgroup.com/cancer-tumor-profiling-market

5. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Cancer Type:
•Breast Cancer
•Lung Cancer
•Colorectal Cancer
•Prostate Cancer
•Melanoma Cancer
•Others
Breakup by Technology:
•Next-Generation Sequencing (NGS)
•Polymerase Chain Reaction (PCR)
•Immunohistochemistry (IHC)
•In-Situ Hybridization (ISH)
•Microarray
•Others

6. Report Description
Report Description and Highlights
Breakup by Technique:
•Genomics
•Proteomics
•Epigenetics
•Metabolomics
Breakup by Application:
•Personalized Medicine
•Diagnostics
•Biomarker Discovery
•Prognostics
•Others
Breakup by Region:
•North America
•Asia Pacific
•Europe
•Latin America
•Middle East and Africa

7. Report Description
Report Description and Highlights
Competitive Landscape with Key Players:
•Abbott Laboratories
•Becton Dickinson and Company
•Caris Life Sciences
•Exact Sciences Corporation
•F. Hoffmann-La Roche Ltd
•Hologic Inc
•HTG Molecular Diagnostics Inc
•Illumina Inc
•Laboratory Corporation of America Holdings
•NeoGenomics Laboratories
•Qiagen N.V
•Siemens AG
•Sysmex Corporation

8. Report Description
Key Questions Answered in the Report
1. What was the size of the global cancer/tumor profiling market in 2021?
2. What is the expected growth rate of the global cancer/tumor profiling market during 2022-
2027?
3. What has been the impact of COVID-19 on the global cancer/tumor profiling market?
4. What are the key factors driving the global cancer/tumor profiling market?
5. What is the breakup of the global cancer/tumor profiling market based on the cancer type?
6. What is the breakup of the global cancer/tumor profiling market based on the technique?
7. What are the key regions in the global cancer/tumor profiling market?
8. Who are the key players/companies in the global cancer/tumor profiling market?

9. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cancer/Tumor Profiling Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

10. Report Description Table of Contents
6 Market Breakup by Cancer Type
6.1 Breast Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Lung Cancer
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Colorectal Cancer
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Prostate Cancer
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Melanoma Cancer
6.5.1 Market Trends
6.5.2 Market Forecast
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/cancer-tumor-profiling-market/toc

11. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

14. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us